Akademik Veri Yönetim Sistemi
MOLECULAR AND CELLULAR BIOCHEMISTRY, cilt.443, sa.1-2, ss.25-36, 2018 (SCI-Expanded)
The cellular control of glucose uptake and glycogen metabolism in mammalian tissues is in part mediated through the regulation of protein-serine/threonine kinases including CK2. Although it participates to several cellular signaling processes, however, its subcellular localization is not well-defined while some documents mentioned its localization change under pathological conditions. The activation/phosphorylation of some proteins including Zn2+-transporter ZIP7 in cardiomyocytes is controlled with CK2 alpha, thereby, inducing changes in the level of intracellular free Zn2+ ([Zn2+](i) ). In this regard, we aimed to examine cellular localization of CK2 alpha in cardiomyocytes and its possible subcellular migration under hyperglycemia. Our confocal imaging together with biochemical analysis in isolated sarco(endo)plasmic reticulum [S(E)R] and nuclear fractions from hearts have shown that CK2 alpha localized highly to S(E)R and Golgi and weakly to nuclear fractions in physiological condition. However, it can migrate from nuclear fractions to S(E)R under hyperglycemia. This migration can further underlie phosphorylation of a target protein ZIP7 as well as some endogenous kinases and phosphatases including PKA, CaMKII, and PP2A. We also have shown that CK2 alpha activation is responsible for hyperglycemia-associated [Zn2+](i) increase in diabetic heart. Therefore, our present data demonstrated, for the first time, the physiological relevance of CK2 alpha in cellular control of Zn2+-distribution via inducing ZIP7 phosphorylation and activation of these above endogenous actors in hyperglycemia/diabetes-associated cardiac dysfunction. Moreover, our present data also emphasized the multi-subcellular compartmental localizations of CK2 alpha and a tightly regulation of these localizations in cardiomyocytes. Therefore, taken into consideration of all data, one can emphasize the important role of the subcellular localization of CK2 alpha as a novel target-pathway for understanding of diabetic cardiomyopathy.